Inclinix
About:
Inclinix focuses on customized Phase I-IV clinical enrollment solutions for pharmaceutical, biotechnology and medical device organizations.
Website: http://inclinix.com
Top Investors: Frontier Growth
Description:
Inclinix, Inc. is a division of Inclinix-PMG Holdings, Inc., the industry's most innovative solution for clinical trial enrollment that combines the world-class sites of PMG Research Inc. with Inclinix's premier patient recruitment solutions. Inclinix specializes in customized Phase I-IV clinical enrollment solutions for global pharmaceutical, biotechnology, and medical device organizations. Clients benefit from twelve years of experience in multiple therapeutic areas, as well as leading edge technologies that meet the challenge of clinical development from feasibility through compliance. Inclinix delivers a customized, site-focused approach to patient recruitment ensuring every available study candidate is identified, qualified and presented with a study opportunity. By combining our powerful in-field approach with social media and highly targeted advertising, Inclinix creates effective outreach campaigns breitling replica watches that result in enrolled patients and productive sites.
$30.6M
Wilmington, North Carolina, United States
1999-01-01
info(AT)inclinix.com
Chris Sleat
51-100
2014-06-19
Private
© 2025 bioDAO.ai